Interleukin-17 receptor (IL-17R) has been recently identified, which exhibits no homology to any known family of receptors. Studies show that soluble mouse IL-17R (smIL-17R) can not only inhibit T-cell activation, but also suppress the response to alloantigen in established allograft transplant models.